Asparagine endopeptidase can initiate the removal of the MHC class II invariant chain chaperone

Immunity

Volumn 18, Issue 4, 2003, Pages 489-498

  Manoury, Bénédicte ^a   Mazzeo, Daniela ^a   Li, Dongtao Ni ^a   Billson, Jeremy ^c   Loak, Kylie ^c   Benaroch, Philippe ^b   Watts, Colin ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b INSTITUT CURIE   (France)

^c MEDIVIR AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; ASPARAGINE ENDOPEPTIDASE; CHAPERONE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MV 026630; PEPTIDE; PROTEINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BINDING SITE; ENZYME ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN ENGINEERING; PROTEIN EXPRESSION; PROTEIN TARGETING;

EID: 0037396716     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(03)00085-2     Document Type: Article

References (62)

1. Alvarez-Fernandez M., Barrett A.J., Gerhartz B., Dando P.M., Ni J., Abrahamson M. Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site. J. Biol. Chem. 272:1999;19195-19203.
2. Amigorena S., Drake J.R., Webster P., Mellman I. Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes. Nature. 369:1994;113-120.
3. Amigorena S., Webster P., Drake J., Newcomb J., Cresswell P., Mellman I. Invariant chain cleavage and peptide loading in major histocompatibility complex class II vesicles. J. Exp. Med. 181:1995;1729-1741.
4. Antoniou A.N., Blackwood S.L., Mazzeo D., Watts C. Control of antigen presentation by a single protease cleavage site. Immunity. 12:2000;391-398.
5. Arneson L.S., Miller J. Efficient endosomal localization of major histocompatibility complex class II-invariant chain complexes requires multimerization of the invariant chain targeting sequence. J. Cell. Biol. 129:1995;1217-1228.
6. Ashman J.B., Miller J. A role for the transmembrane domain in the trimerization of the MHC class II-associated invariant chain. J. Immunol. 163:1999;2704-2712.
7. Bakke O., Dobberstein B. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell. 63:1990;707-716.
8. Bijlmakers M.J., Benaroch P., Ploegh H.L. Assembly of HLA DR1 molecules translated in vitro. binding of peptide in the endoplasmic reticulum precludes association with invariant chain EMBO J. 13:1994;2699-2707. a.
9. Bijlmakers M.J., Benaroch P., Ploegh H.L. Mapping functional regions in the lumenal domain of the class II-associated invariant chain. J. Exp. Med. 180:1994;623-629. b.
10. Blum J.S., Cresswell P. Role for intracellular proteases in the processing and transport of class II HLA antigens. Proc. Natl. Acad. Sci. USA. 85:1988;3975-3979.
11. Bogyo M., Verhelst S., Bellingard-Dubouchaud V., Toba S., Greenbaum D. Selective targeting of lysosomal cysteine proteases with radiolabeled electrophilic substrate analogs. Chem. Biol. 7:2000;27-38.
12. Brachet V., Raposo G., Amigorena S., Mellman I. Ii chain controls the transport of major histocompatibility complex class II molecules to and from lysosomes. J. Cell Biol. 137:1997;51-65.
13. Busch R., Cloutier I., Sekaly R.P., Hammerling G.J. Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum. EMBO J. 15:1996;418-428.
14. Chen J.M., Rawlings N.D., Stevens R.A.E., Barrett A.J. Identification of the active site of legumain links it to caspases, clostripain and gingipains in a new clan of cystein endopeptidases. FEBS Lett. 441:1998;361-365.
15. Chen J.M., Dando P.M., Rawlings N.D., Brown M.A., Young N.E., Stevens R.A., Hewitt E., Watts C., Barrett A.J. Cloning, isolation, and characterization of mammalian legumain, an asparaginyl endopeptidase. J. Biol. Chem. 272:1997;8090-8098.
16. Cresswell P. Assembly, transport, and function of class II MHC molecules. Annu. Rev. Immunol. 12:1994;259-293.
17. Davidson H.W., West M.A., Watts C. Endocytosis, intracellular trafficking, and processing of membrane IgG and monovalent antigen/membrane IgG complexes in B lymphocytes. J. Immunol. 144:1990;4101-4109.
18. Davidson H.W., Reid P.A., Lanzavecchia A., Watts C. Processed antigen binds to newly synthesized class II MHC molecules in antigen-specific B lymphocytes. Cell. 67:1991;105-116.
19. Germain R.N., Hendrix L.R. Class II MHC structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature. 353:1991;134-139.
20. Ghosh P., Amaya M., Mellins E., Wiley D.C. The structure of an intermediate in class II MHC maturation. CLIP bound to HLA-DR3 Nature. 378:1995;457-462.
21. Hewitt C.R., Lamb J.R., Hayball J., Hill M., Owen M.J., O'Hehir R.E. Major histocompatibility complex independent clonal T cell anergy by direct interaction of Staphylococcus aureus enterotoxin B with the T cell antigen receptor. J. Exp. Med. 175:1992;1493-1499.
22. Honey K., Nakagawa T., Peters C., Rudensky A. Cathepsin L regulates CD4+ T cell selection independently of its effect on invariant chain. a role in the generation of positively selecting peptide ligands J. Exp. Med. 195:2002;1349-1358.
23. Hsieh C.S., deRoos P., Honey K., Beers C., Rudensky A.Y. A role for cathepsin L and cathepsin S in peptide generation for class II MHC presentation. J. Immunol. 168:2002;2618-2625.
24. Jasanoff A., Wagner G., Wiley D.C. Structure of a trimeric domain of the MHC class II-associated chaperonin and targeting protein Ii. EMBO J. 17:1998;6812-6818.
25. Knight A.M., Lucocq J.M., Prescott A.R., Ponnambalam S., Watts C. Antigen endocytosis and presentation mediated by human membrane IgG1 in the absence of the Ig(alpha)/Ig(beta) dimer. EMBO J. 16:1997;3842-3850.
26. Kvist S., Wiman K., Claesson L., Peterson P.A., Dobberstein B. Membrane insertion and oligomeric assembly of HLA-DR histocompatibility antigens. Cell. 29:1982;61-69.
27. Lamb C.A., Cresswell P. Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes. J. Immunol. 148:1992;3478-3482.
28. Lotteau V., Teyton L., Peleraux A., Nilsson T., Karlsson L., Schmid S.L., Quaranta V., Peterson P.A. Intracellular transport of class II MHC molecules directed by invariant chain. Nature. 348:1990;600-605.
29. Machamer C.E., Cresswell P. Biosynthesis and glycosylation of the invariant chain associated with HLA-DR antigens. J. Immunol. 129:1982;2564-2569.
30. Manoury B., Hewitt E.W., Morrice N., Dando P.M., Barrett A.J., Watts C. An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation. Nature. 396:1998;695-699.
31. Manoury B., Mazzeo D., Fugger L., Viner N., Ponsford M., Streeter H., Mazza G., Wraith D.C., Watts C. Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP. Nat. Immunol. 3:2002;169-174.
32. Maric M.A., Taylor M.D., Blum J.S. Endosomal aspartic proteinases are required for invariant-chain processing. Proc. Natl. Acad. Sci. USA. 91:1994;2171-2175.
33. Morton P.A., Zacheis M.L., Giacoletto K.S., Manning J.A., Schwartz B.D. Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells. J. Immunol. 154:1995;137-149.
34. Nakagawa T., Roth W., Wong P., Nelson A., Farr A., Deussing J., Villadangos J.A., Ploegh H., Peters C., Rudensky A.Y. Cathepsin L. critical role in Ii degradation and CD4 T cell selection in the thymus Science. 280:1998;450-453.
35. Nakagawa T.Y., Brissette W.H., Lira P.D., Griffiths R.J., Petrushova N., Stock J., McNeish J.D., Eastman S.E., Howard E.D., Clarke S.R.M.et al. Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. Immunity. 10:1999;207-217.
36. Neefjes J.J., Ploegh H.L. Inhibition of endosomal proteolytic activity by leupeptin blocks surface expression of class II MHC molecules and their conversion to SDS resistance alpha beta heterodimers in endosomes. EMBO J. 11:1992;411-416.
37. Newcomb J.R., Cresswell P. Structural analysis of proteolytic products of MHC class II-invariant chain complexes generated in vivo. J. Immunol. 151:1993;4153-4163.
38. Nguyen Q.V., Knapp W., Humphreys R.E. Inhibition by leupeptin and antipain of the intracellular proteolysis of Ii. Hum. Immunol. 24:1989;153-163.
39. Pieters J., Horstmann H., Bakke O., Griffiths G., Lipp J. Intracellular transport and localization of major histocompatibility complex class II molecules and associated invariant chain. J. Cell Biol. 115:1991;1213-1223.
40. Pluger E.B., Boes M., Alfonso C., Schroter C.J., Kalbacher H., Ploegh H.L., Driessen C. Specific role for cathepsin S in the generation of antigenic peptides in vivo. Eur. J. Immunol. 32:2002;467-476.
41. Pond L., Watts C. Functional early endosomes are required for maturation of major histocompatibility complex class II molecules in human B lymphoblastoid cells. J. Biol. Chem. 274:1999;18049-18054.
42. Pond L., Kuhn L.A., Teyton L., Schutze M.P., Tainer J.A., Jackson M.R., Peterson P.A. A role for acidic residues in di-leucine motif-based targeting to the endocytic pathway. J. Biol. Chem. 270:1995;19989-19997.
43. Riberdy J.M., Avva R.R., Geuze H.J., Cresswell P. Transport and intracellular distribution of class II MHC molecules and associated invariant chain in normal and antigen-processing mutant cell lines. J. Cell Biol. 125:1994;1225-1237.
44. Riese R.J., Chapman H.A. Cathepsins and compartmentalization in antigen presentation. Curr. Opin. Immunol. 12:2000;102-113.
45. Riese R.J., Wolf P.R., Bromme D., Natkin L.R., Villadangos J.A., Ploegh H.L., Chapman H.A. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity. 4:1996;357-366.
46. Roche P.A., Cresswell P. Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules. Proc. Natl. Acad. Sci. USA. 88:1991;3150-3154.
47. Roche P.A., Marks M.S., Cresswell P. Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain. Nature. 354:1991;392-394.
48. Romagnoli P., Germain R.N. The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy. J. Exp. Med. 180:1994;1107-1113.
49. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179:1994;1109-1118.
50. Sant A.J., Miller J. Class II MHC antigen processing. biology of invariant chain Curr. Opin. Immunol. 6:1994;57-63.
51. Shi G.P., Villadangos J.A., Dranoff G., Small C., Gu L., Haley K.J., Riese R., Ploegh H.L., Chapman H.A. Cathepsin S required for normal class II MHC peptide loading and germinal center development. Immunity. 10:1999;197-206.
52. Shi G.P., Bryane A.R., Riese R., Verhelse S., Driessen C., Li Z., Bromme D., Ploegh H.L., Chapman H.A. Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages. J. Exp. Med. 191:2000;1177-1185.
53. Stumptner P., Benaroch P. Interaction of class II MHC molecules with the invariant chain. role of the invariant chain (81-90) region EMBO J. 16:1997;5807-5818.
54. Stumptner-Cuvelette P., Benaroch P. Multiple roles of the invariant chain in class II MHC function. Biochim. Biophys. Acta. 1542:2002;1-13.
55. Tulp A., Verwoerd D., Dobberstein B., Ploegh H.L., Pieters J. Isolation and characterization of the intracellular class II MHC compartment. Nature. 369:1994;120-126.
56. Villadangos J.A., Ploegh H.L. Proteolysis in class II MHC antigen presentation. who's in charge? Immunity. 12:2000;233-239.
57. Villadangos J.A., Riese R.J., Peters C., Chapman H.A., Ploegh H.L. Degradation of mouse invariant chain. roles of cathepsins S and D and the influence of major histocompatibility complex polymorphism J. Exp. Med. 186:1997;549-560.
58. Vincent-Schneider H., Thery C., Mazzeo D., Tenza D., Raposo G., Bonnerot C. Secretory granules of mast cells accumulate mature and immature class II MHC molecules. J. Cell Sci. 114:2001;323-334.
59. Watts C. Antigen processing in the endocytic compartment. Curr. Opin. Immunol. 13:2001;26-31.
60. West M.A., Lucocq J.M., Watts C. Antigen processing and class II MHC peptide-loading compartments in human B-lymphoblastoid cells. Nature. 369:1994;147-151.
61. Xing R., Addington A.K., Mason R.W. Quantification of cathepsins B and L in cells. Biochem. J. 332:1998;499-505.
62. Zhong G., Castellino F., Romagnoli P., Germain R.N. Evidence that binding site occupancy is necessary and sufficient for effective major histocompatibility complex (MHC) class II transport through the secretory pathway redefines the primary function of class II-associated invariant chain peptides (CLIP). J. Exp. Med. 184:1996;2061-2066.